The World Health Organisation (Who) Has Validated The Sinovac-Coronavac Covid-19 Vaccine For Emergency Use, Giving Countries, Funders, Procuring Agencies And Communities The Assurance That It Meets International Standards For Safety, Efficacy And Manufacturing. The Vaccine Is Produced By The Beijing-Based Pharmaceutical Company Sinovac.&Ldquo;The World Desperately Needs Multiple Covid-19 Vaccines To Address The Huge Access Inequity Across The Globe,&Rdquo; Said Dr MariÂNgela SimÃO, Who Assistant-Director General For Access To Health Products. &Ldquo;We Urge Manufacturers To Participate In The Covax Facility, Share Their Knowhow And Data And Contribute To Bringing The Pandemic Under Control.&Rdquo;Who&Rsquo;S Emergency Use Listing (Eul) Is A Prerequisite For Covax Facility Vaccine Supply And International Procurement. It Also Allows Countries To Expedite Their Own Regulatory Approval To Import And Administer Covid-19 Vaccines. The Sinovac-Coronavac Product Is An Inactivated Vaccine. Its Easy Storage Requirements Make It Very Manageable And Particularly Suitable For Low-Resource Settings.